Wave Life Sciences (WVE) Invested Capital: 2015-2025
Historic Invested Capital for Wave Life Sciences (WVE) over the last 10 years, with Sep 2025 value amounting to $124.5 million.
- Wave Life Sciences' Invested Capital fell 12.07% to $124.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.5 million, marking a year-over-year decrease of 12.07%. This contributed to the annual value of $209.5 million for FY2024, which is 428.68% up from last year.
- Wave Life Sciences' Invested Capital amounted to $124.5 million in Q3 2025, which was down 10.57% from $139.3 million recorded in Q2 2025.
- In the past 5 years, Wave Life Sciences' Invested Capital registered a high of $209.5 million during Q4 2024, and its lowest value of -$51.7 million during Q2 2023.
- Moreover, its 3-year median value for Invested Capital was $39.6 million (2023), whereas its average is $65.6 million.
- Its Invested Capital has fluctuated over the past 5 years, first slumped by 65,398.11% in 2023, then skyrocketed by 4,105.35% in 2025.
- Over the past 5 years, Wave Life Sciences' Invested Capital (Quarterly) stood at $32.5 million in 2021, then slumped by 238.75% to -$45.1 million in 2022, then skyrocketed by 187.89% to $39.6 million in 2023, then skyrocketed by 428.68% to $209.5 million in 2024, then dropped by 12.07% to $124.5 million in 2025.
- Its Invested Capital was $124.5 million in Q3 2025, compared to $139.3 million in Q2 2025 and $171.8 million in Q1 2025.